Posted on May 24, 20225/24/22
Overcome In-Licensing Barriers to Increase Throughput of Assets
Posted on May 13, 20225/13/22
Is Your Digital Communication Strategy Up to Par?
Posted on January 28, 20221/28/22
How to Ensure Speed and Efficiency When Launching in Europe
Posted on January 26, 20221/26/22
Reversing the Complexity of Oncology Commercialization: How to solve for launch challenges in a chaotic ecosystem
Posted on January 20, 20221/20/22
A Holistic Launch in Europe Is Possible, But Change Is Necessary
Posted on December 22, 202112/22/21
Why Launching in Europe Is Unlike Launching Anywhere Else
Posted on October 5, 202110/5/21
WEBINAR: The New Path to European Pharmaceutical Commercialisation
Posted on September 30, 20219/30/21
EPP Studio Live Webinar — Looking Ahead: Landscape of the Key Price and Market Access Trends in Europe
Posted on September 14, 20219/14/21
Simplifying EU Distribution to Maximize Cost Efficiency and Speed to Market for Patients and Manufacturers
Posted on June 29, 20216/29/21